Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Oramed Pharmaceuticals (ORMP) Shares Outstanding (Weighted Average) (2016 - 2026)

Oramed Pharmaceuticals filings provide 15 years of Shares Outstanding (Weighted Average) readings, the most recent being $41.4 million for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 1.35% to $41.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $41.4 million through Dec 2025, up 1.35% year-over-year, with the annual reading at $41.4 million for FY2025, 1.35% up from the prior year.
  • Shares Outstanding (Weighted Average) hit $41.4 million in Q4 2025 for Oramed Pharmaceuticals, down from $41.8 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $41.8 million in Q3 2025 and bottomed at $26.9 million in Q2 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $38.2 million, with a median of $40.2 million recorded in 2023.
  • The largest annual shift saw Shares Outstanding (Weighted Average) surged 54.38% in 2021 before it grew 0.96% in 2025.
  • Oramed Pharmaceuticals' Shares Outstanding (Weighted Average) stood at $36.7 million in 2021, then increased by 6.34% to $39.0 million in 2022, then rose by 3.38% to $40.3 million in 2023, then rose by 1.33% to $40.9 million in 2024, then increased by 1.35% to $41.4 million in 2025.
  • Per Business Quant, the three most recent readings for ORMP's Shares Outstanding (Weighted Average) are $41.4 million (Q4 2025), $41.8 million (Q3 2025), and $41.7 million (Q2 2025).